𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low Frequency ofBCL10Gene Mutations in B-Cell Non-Hodgkin’s Lymphoma

✍ Scribed by Jiro Tadokoro; Yuichi Nakamura; Shinpei Furusawa; Kinuko Mitani


Publisher
Carden Jennings Publishing
Year
2001
Tongue
English
Weight
81 KB
Volume
73
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


p53 gene Mutations and rearrangements in
✍ Po-Min Chen; Tzeon-Jye Chiou; Ruey-Kuen Hsieh; Frank S. Fan; Chiau-Jun Chu; Chin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

## Background: Alterations of the p53 gene have been associated with the progression of certain human malignancies. to establish further the correlation between p53 gene alterations and progression of non-hodgkin's lymphomas (nhls), the authors analyzed both mutations and rearrangements of the p53

CD45 expression in low-grade B-cell non-
✍ Giovanni Carulli; Elisa Cannizzo; Alessandra Zucca; Gabriele Buda; Enrico Orciuo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 223 KB

CD45 is a glycoprotein expressed in all lymphohemopoietic cells. Its expression increases during B-lymphocyte ontogeny. Few data are available about CD45 expression in the various types of low-grade B-cell non-Hodgkin's lymphomas (NHL). Low levels of CD45 have been reported in pathologic lymphocytes

Analysis of PTEN mutations and deletions
✍ Marion P. Butler; Steven I. Wang; R.S.K. Chaganti; Ramon Parsons; Riccardo Dalla 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

The PTEN gene is involved in 10q23 deletions in several types of cancer, including glioma, melanoma, endometrial and prostate carcinomas. The PTEN gene product is a dual-specificity phosphatase with putative tumor suppressor function. Deletions and rearrangements of 10q22-25 have been reported in ϳ5

Thymic B-cell non-Hodgkin's lymphoma in
✍ Azuma, Eiichi; Nishihara, Hidehiro; Qi, Jiang; Nagai, Masataka; Hiratake, Shinya 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 776 KB

A 13-year-old male developed thymic non-Hodgkin's lymphoma. Microscopically, the tumor was composed of large cells, resembling centroblasts. Immunohistochemically, the tumor demonstrated leukocyte common antigen+, L26 (B-cell)+, UCHL1 (T-cell)-, suggesting the B-cell phenotype. In contrast to the te